For Research Purposes Only

hormonal

CJC-1295 for Growth Hormone Deficiency

Phase 2 clinical trials

How It Works

GHRH analog that stimulates pituitary GH release with sustained elevation.

Research Evidence

Research is ongoing. Consult current literature for latest evidence.

Dosing Protocol

100mcg (no DAC) 2-3x daily or 2mg (with DAC) twice weekly.

Important Considerations

  • !Not FDA approved
  • !Requires injection
  • !Quality varies
  • !Consult healthcare provider before use
  • !Quality sourcing is critical

Frequently Asked Questions

Does CJC-1295 work for growth hormone deficiency?

Research is ongoing. Consult current literature for latest evidence. Research level: Phase 2 clinical trials.

How does CJC-1295 help with growth hormone deficiency?

GHRH analog that stimulates pituitary GH release with sustained elevation.

What is the CJC-1295 dosage for growth hormone deficiency?

100mcg (no DAC) 2-3x daily or 2mg (with DAC) twice weekly.

Is CJC-1295 safe for growth hormone deficiency?

Key considerations: Not FDA approved. Requires injection. Quality varies. Consult healthcare provider before use. Quality sourcing is critical. Always consult a healthcare provider.

How long until CJC-1295 works for growth hormone deficiency?

Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.

Learn More

Disclaimer: This information is for educational and research purposes only. CJC-1295 is not FDA approved for this use. Consult qualified healthcare professionals.